Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
breast cancer
Aug 19, 2023, 20:05 |
Insight
Why patients with triple negative breast cancer respond differently to treatment. - The Institute of Cancer Research
The Institute of Cancer Research, made the following remark on Twitter: "Our scientists have looked into…
Aug 19, 2023, 17:44 |
Insight
Kathryn Gallaway: Continuing our discussion on disparities in breast cancer.
Quoting Kathryn Gallaway, the Associate Medical Director of DAVA Oncology, on Twitter: "Continuing our discussion…
Aug 18, 2023, 16:55 |
Blog
Targeting Mutant ER: Geoffrey L. Greene, François-Clément Bidard, and Erika P. Hamilton will address this topic in a State-of-the-Art session at SABCS23 - San Antonio Breast Cancer Symposium
Aug 18, 2023, 04:56 |
Insight
Nicola Fusco: The assessment of PDL1 Combined Positive Score (CPS)≥10 in metastatic triple-negative breast cancer.
Nicola Fusco, an Associate Professor at the Department of Oncology and Hemato-Oncology at the University…
Aug 16, 2023, 18:20 |
Opinion
James Coyne: The article provides a summary of my thinking about a seriously flawed study that gave false hope to breast cancer patients.
Quoting from a recent LinkedIn post by James Coyne, Emeritus Professor of Psychology in Psychiatry…
Aug 15, 2023, 09:15 |
Insight
Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC)
Paolo Tarantino, MD, Clinical Research Fellow at Dana-Farber Cancer Institute, stated on Twitter: "Delivering chemo…
Aug 14, 2023, 17:39 |
Insight
Check out the new review just published in Cancers MDPI on Tumor Mutational Burden in Breast Cancer - Dana-Farber’s Breast Oncology Center
Quoting from a recent tweet by Dana-Farber’s Breast Oncology Center: "Check out the new review…
Aug 13, 2023, 23:42 |
Blog
Aurélie Degeneffe: Women with meningioma have a higher lifetime risk of breast cancer compared to the general female population
Quoting Aurélie Degeneffe, a neurosurgeon from the UZ Brussels, "A recent meta-analysis published in JAMA…
Aug 9, 2023, 18:36 |
Career
Evanthia Roussos Torres recently was awarded R01 funding from the National Cancer Institute to investigate how targeting myeloid suppression enhances anti-tumor immunity in breast cancer - Caryn Lerman
Aug 8, 2023, 04:32 |
Blog
Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy - Orit Kaidar-Person
64
65
66
67
68
All:
2604
Posts:
651 - 660
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube